IRVAX
Price
$24.16
Change
-$0.21 (-0.86%)
Updated
Jun 13 closing price
Net Assets
266.26M
VIVAX
Price
$67.64
Change
-$0.55 (-0.81%)
Updated
Jun 13 closing price
Net Assets
188.77B
Interact to see
Advertisement

IRVAX vs VIVAX

Header iconIRVAX vs VIVAX Comparison
Open Charts IRVAX vs VIVAXBanner chart's image
Voya Russell Large Cap Value Idx Port A
Price$24.16
Change-$0.21 (-0.86%)
VolumeN/A
Net Assets266.26M
Vanguard Value Index I
Price$67.64
Change-$0.55 (-0.81%)
VolumeN/A
Net Assets188.77B
IRVAX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IRVAX vs. VIVAX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRVAX is a Hold and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. IRVAX (266M). IRVAX pays higher dividends than VIVAX: IRVAX (7.38) vs VIVAX (2.16). IRVAX was incepted earlier than VIVAX: IRVAX (10 years) vs VIVAX (33 years). IRVAX (0.94) is less costly to investors than VIVAX (0.17). IRVAX is a more actively managed with annual turnover of: 36.00 vs. VIVAX (9.00). IRVAX has a lower initial minimum investment than VIVAX: IRVAX (0) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 8.01 vs. IRVAX (-10.42). VIVAX return over 5 years is better than : 72.56 vs. IRVAX (40.53).
IRVAXVIVAXIRVAX / VIVAX
Total Expense Ratio0.840.17494%
Annual Report Gross Expense Ratio0.940.17553%
Fund Existence10 years33 years-
Gain YTD-16.5522.419-684%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets266M189B0%
Annual Yield % from dividends7.382.16342%
Returns for 1 year-10.428.01-130%
Returns for 3 years10.4232.2032%
Returns for 5 years40.5372.5656%
Returns for 10 years52.61103.5451%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSUR2.950.02
+0.68%
OraSure Technologies
ROIV11.32-0.15
-1.31%
Roivant Sciences Ltd
PYXS1.20-0.02
-1.64%
Pyxis Oncology
FOLD6.03-0.14
-2.27%
Amicus Therapeutics
SAP293.36-8.38
-2.78%
SAP SE